Skip to content

Evaluation of procalcitonin for early diagnosis of acute radiation-induced lung injury

Evaluation of procalcitonin for early diagnosis of acute radiation-induced lung injury

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17010933
Enrollment
Unknown
Registered
2017-03-20
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

radiation-induced lung injury

Interventions

Gold Standard:CT image

Sponsors

Tangshan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients with lung cancer who received thoracic radiotherapy within 6 months; 2) Aged greater than or equal to 18 years; 3) New radiological abnormalities(CT images): Ground glass opacitiespatchy, consolidation conforming to the outline of the sharply demarcated irradiated area, or non-uniform Ground glass opacitiespatchy and discrete consolidation; 4) New clinical symptoms: cough; dyspnea; thoracic pain; fever

Exclusion criteria

Exclusion criteria: The standard symptoms and signs caused by the following factors: tumor progression, COPD acute exacerbation, cardiogenic disease, pulmonary infarction, anemia and so on.

Design outcomes

Primary

MeasureTime frame
Procalcitonin;

Secondary

MeasureTime frame
High sensitivity C reactive protein;

Countries

China

Contacts

Public ContactHu Wanning

Tangshan People's Hospital

rmyy_hwn@163.com+86 13363269688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026